REGULATION 2019 Revision
Drug Administration Law of the People's Republic of China (2019 Revision)
ABSTRACT — EDITORS' SUMMARY
The parent statute for all drug regulation in China. Chapter II covers clinical trial requirements. Chapter X covers inspection and enforcement powers. The statutory authority underneath GCP No. 57 and the Drug Registration Provisions.
LIVE SOURCE · CONTINUOUSLY UPDATED
Read live on english.nmpa.gov.cn ↗ METADATA
SOURCE
HTML · CANONICAL LINK https://english.nmpa.gov.cn/2019-09/26/c_773012.htm ↗ RELATED · SAME AUTHORITY